Thrombo-inflammation in Cardiometabolic Disease

Area of Science:

• Cardiovascular Medicine
• Metabolic Disorders
• Immunology
• Hematology

Background:

• Cardiometabolic diseases such as obesity and diabetes are associated with heightened coagulation, inflammation, and immune responses.
• These physiological states increase the risk of thromboembolism and stroke.
• Understanding the interplay between cardiometabolic health and thrombo-inflammation is crucial for clinical outcomes.

Purpose of the Study:

• To review the bidirectional relationship between thrombo-inflammation and cardiometabolic disease.
• To elucidate the mechanisms by which metabolic disorders trigger pro-coagulant states.
• To explore potential biomarkers and therapeutic strategies for managing these interconnected conditions.

Main Methods:

• Review of recent clinical and basic science literature.
• Analysis of causal links between coagulation, inflammation, and metabolic disorders.
• Discussion of endothelial dysfunction, platelet activity, and fibrinolysis balance.

Main Results:

• Metabolic disorders initiate a pro-coagulant state via endothelial dysfunction and platelet hyperreactivity.
• Inflammation and immune signaling significantly impact cardiac and adipose tissues.
• Candidate biomarkers for early detection of thrombo-inflammation have been identified.

Conclusions:

• Thrombo-inflammation is intricately linked with cardiometabolic disease, influencing clinical outcomes.
• Further research into sex differences and therapeutic interventions is warranted.
• Biomarker signatures may improve the timely detection and management of thrombo-inflammatory states.